These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
389 related items for PubMed ID: 29943979
1. Synthesis, Structure, and Cytotoxicity of Oxaliplatin-Based Platinum(IV) Anticancer Prodrugs Bearing One Axial Fluoride. Xu Z, Chan HM, Li C, Wang Z, Tse MK, Tong Z, Zhu G. Inorg Chem; 2018 Jul 16; 57(14):8227-8235. PubMed ID: 29943979 [Abstract] [Full Text] [Related]
2. Stability, Reduction, and Cytotoxicity of Platinum(IV) Anticancer Prodrugs Bearing Carbamate Axial Ligands: Comparison with Their Carboxylate Analogues. Chen S, Yao H, Zhou Q, Tse MK, Gunawan YF, Zhu G. Inorg Chem; 2020 Aug 17; 59(16):11676-11687. PubMed ID: 32799457 [Abstract] [Full Text] [Related]
3. Platinum(IV) Complexes of trans-1,2-diamino-4-cyclohexene: Prodrugs Affording an Oxaliplatin Analogue that Overcomes Cancer Resistance. Papadia P, Micoli K, Barbanente A, Ditaranto N, Hoeschele JD, Natile G, Marzano C, Gandin V, Margiotta N. Int J Mol Sci; 2020 Mar 27; 21(7):. PubMed ID: 32230896 [Abstract] [Full Text] [Related]
4. Oxidation of anticancer Pt(II) complexes with monodentate phosphane ligands: towards stable but active Pt(IV) prodrugs. Medrano MÁ, Álvarez-Valdés A, Perles J, Lloret-Fillol J, Muñoz-Galván S, Carnero A, Navarro-Ranninger C, Quiroga AG. Chem Commun (Camb); 2013 May 25; 49(42):4806-8. PubMed ID: 23591566 [Abstract] [Full Text] [Related]
5. Dual-acting antitumor Pt(iv) prodrugs of kiteplatin with dichloroacetate axial ligands. Savino S, Gandin V, Hoeschele JD, Marzano C, Natile G, Margiotta N. Dalton Trans; 2018 May 29; 47(21):7144-7158. PubMed ID: 29766157 [Abstract] [Full Text] [Related]
6. Optimization of axial ligands to promote the photoactivation of BODIPY-conjugated platinum(IV) anticancer prodrugs. Yao H, Gunawan YF, Liu G, Tse MK, Zhu G. Dalton Trans; 2021 Oct 12; 50(39):13737-13747. PubMed ID: 34519297 [Abstract] [Full Text] [Related]
14. Strategy for Traceless Codrug Delivery with Platinum(IV) Prodrug Complexes Using Self-Immolative Linkers. Lee VEY, Lim ZC, Chew SL, Ang WH. Inorg Chem; 2021 Feb 01; 60(3):1823-1831. PubMed ID: 33464875 [Abstract] [Full Text] [Related]
15. Pt(IV) antitumor prodrugs: dogmas, paradigms, and realities. Ravera M, Gabano E, McGlinchey MJ, Osella D. Dalton Trans; 2022 Feb 08; 51(6):2121-2134. PubMed ID: 35015025 [Abstract] [Full Text] [Related]
16. Cellular trafficking, accumulation and DNA platination of a series of cisplatin-based dicarboxylato Pt(IV) prodrugs. Ravera M, Gabano E, Zanellato I, Bonarrigo I, Alessio M, Arnesano F, Galliani A, Natile G, Osella D. J Inorg Biochem; 2015 Sep 08; 150():1-8. PubMed ID: 26042542 [Abstract] [Full Text] [Related]
18. Facile preparation of mono-, di- and mixed-carboxylato platinum(IV) complexes for versatile anticancer prodrug design. Zhang JZ, Bonnitcha P, Wexselblatt E, Klein AV, Najajreh Y, Gibson D, Hambley TW. Chemistry; 2013 Jan 28; 19(5):1672-6. PubMed ID: 23255183 [Abstract] [Full Text] [Related]
19. Influence of equatorial and axial carboxylato ligands on the kinetic inertness of platinum(IV) complexes in the presence of ascorbate and cysteine and within DLD-1 cancer cells. Chen CK, Zhang JZ, Aitken JB, Hambley TW. J Med Chem; 2013 Nov 14; 56(21):8757-64. PubMed ID: 24107138 [Abstract] [Full Text] [Related]